Evidence map›Paper›PMID 37306039›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2023

P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial.

Patricia O Guimarães, Marcelo Franken, Caio A M Tavares, Fabio S Silveira, Murillo O Antunes, Ricardo R Bergo, Rodrigo M Joaquim, Jessica C S Hirai, Pedro B Andrade, Fabio G Pitta and 24 more

Registry-linked trialOpen access · greenAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04360720 (PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04360720 phase3completednot on this map

PercutaNEOus Coronary Intervention Followed by Monotherapy INstead of Dual Antiplatelet Therapy in the SETting of Acute Coronary Syndromes: The NEO-MINDSET Trial

TypeinterventionalSponsorHospital Israelita Albert EinsteinRan2020 to 2024Enrolled3,410ConditionsAcute Coronary SyndromeArmsAntiplatelet Monotherapy
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 15 institutions in 4 countries.

Patricia O GuimarãesHospital Israelita Albert Einstein, São Paulo, Brazil.
Marcelo FrankenHospital Israelita Albert Einstein, São Paulo, Brazil.
Caio A M TavaresHospital Israelita Albert Einstein, São Paulo, Brazil.
Fabio S SilveiraResearch Center, Clínica do Coração, Aracaju, Brazil.
Murillo O AntunesHospital Universitário São Francisco de Assis na Providência de Deus, Bragança Paulista, Brazil.
Ricardo R BergoHospital Santa Lucia, Poços de Caldas, Brazil.
Rodrigo M JoaquimInstituto de Cardiologia de Santa Catarina, São José, Brazil.
Jessica C S HiraiHospital Israelita Albert Einstein, São Paulo, Brazil.
Pedro B AndradeIrmandade da Santa Casa de Misericórdia de Marilia, Marilia, Brazil.
Fabio G PittaHospital Israelita Albert Einstein, São Paulo, Brazil.
José MarianiHospital Israelita Albert Einstein, São Paulo, Brazil.
Bruno R NascimentoHospital Universitário Ciências Médicas, Belo Horizonte, Brazil.
João E T de PaulaInstituto Cardiovascular de Linhares, Linhares, Brazil.
Marcos S SilveiraResearch Center, Clínica do Coração, Aracaju, Brazil.
Tiberio A O CostaHospital Universitário São Francisco de Assis na Providência de Deus, Bragança Paulista, Brazil.
Frederico T C Dall'OrtoHospital Santa Lucia, Poços de Caldas, Brazil.
Renato G SerpaHospital Santa Casa de Misericórdia de Vitória, Vitória, Brazil.
Fernanda B A SampaioInstituto Nacional de Cardiologia, Rio de Janeiro, Brazil.
Louis N OheDante Pazzanese Institute of Cardiology, São Paulo, Brazil.
Fernanda M MangioneBeneficência Portuguesa de São Paulo, São Paulo, Brazil.
Remo H M FurtadoInstituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, São Paulo, Brazil and Universidade de São Paulo, São Paulo, Brazil.
Rogerio Sarmento-LeiteInstituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Cardiologia, Porto Alegre, Brazil.
Frederico MonfardiniHospital Israelita Albert Einstein, São Paulo, Brazil.
Silvia R L AssisHospital Israelita Albert Einstein, São Paulo, Brazil.
José C NicolauInstituto do Coracao (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, São Paulo, Brazil and Universidade de São Paulo, São Paulo, Brazil.
Andrei C SpositoDepartment of Internal Medicine, School of Medical Sciences, State University of Campinas, Campinas, Brazil.
Renato D LopesDuke Clinical Research Institute, Duke University, Durham, NC, USA.
Yoshinobu OnumaDepartment of Cardiology, University of Galway, Galway, Ireland.
Marco ValgimigliCardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Dominick J AngiolilloDivision of Cardiology, University of Florida College of Medicine, Jacksonville, FL, USA.
Patrick W SerruysDepartment of Cardiology, University of Galway, Galway, Ireland.
Otavio BerwangerHospital Israelita Albert Einstein, São Paulo, Brazil.
Fernando BacalHospital Israelita Albert Einstein, São Paulo, Brazil.
Pedro A LemosHospital Israelita Albert Einstein, São Paulo, Brazil.
Hospital Israelita Albert Einstein · BROllscoil na Gaillimhe – University of Galway · IEBeneficência Portuguesa de São Paulo · BRDuke University · USEnte Ospedaliero Cantonale · CHEscola Superior de Ciências da Santa Casa de Misericórdia de Vitória · BRFaculdade de Ciências Médicas de Minas Gerais · BRFlorida College · USFundação Universitária de Cardiologia · BRInstituto Dante Pazzanese de Cardiologia · BRInstituto de Cardiologia de Santa Catarina · BRInstituto de Pesquisas Energéticas e Nucleares · BRInstituto Nacional de Cardiologia · BRSanta Casa de Misericórdia de Marília · BRUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dual antiplatelet therapy (DAPT) is currently the standard of care after percutaneous coronary intervention (PCI). Recent studies suggest that reducing DAPT to 1-3 months followed by an aspirin-free single antiplatelet therapy (SAPT) strategy with a potent P2Y

Indexed as

Acute Coronary SyndromeDrug-Eluting StentsPercutaneous Coronary InterventionAspirinDrug Therapy, CombinationHemorrhageHumansMulticenter Studies as TopicPlatelet Aggregation InhibitorsPrasugrel HydrochlorideRandomized Controlled Trials as TopicTicagrelorTreatment OutcomeAspirinPlatelet Aggregation InhibitorsPrasugrel HydrochlorideTicagrelor

Identifiers

PMID37306039
PMCPMC10333918
OpenAlexW4380290962

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.